(19)
(11) EP 4 771 025 A1

(12)

(43) Date of publication:
08.07.2026 Bulletin 2026/28

(21) Application number: 24782612.6

(22) Date of filing: 16.09.2024
(51) International Patent Classification (IPC): 
C07F 9/59(2006.01)
A61P 25/28(2006.01)
C07F 9/26(2006.01)
(52) Cooperative Patent Classification (CPC):
C07F 9/59; A61P 25/28; C07F 9/26
(86) International application number:
PCT/GB2024/052396
(87) International publication number:
WO 2025/062117 (27.03.2025 Gazette 2025/13)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 22.09.2023 GB 202314609

(71) Applicant: University College Cardiff Consultants Limited
Cardiff South Wales CF10 3AT (GB)

(72) Inventors:
  • LLOYD-EVANS, Emyr
    Cardiff CF10 3AX (GB)
  • PERTUSATI, Fabrizio
    Cardiff University Main Building Park Place Cardiff CF10 3AT (GB)
  • SERPI, Michaela
    Cardiff University Main Building Park Place Cardiff CF10 3AT (GB)
  • WALLER-EVANS, Helen
    Cardiff CF10 3AX (GB)

(74) Representative: Symbiosis IP Limited 
The Innovation Centre 217 Portobello
Sheffield, South Yorkshire S1 4DP
Sheffield, South Yorkshire S1 4DP (GB)

   


(54) COMPOUNDS FOR NEURODEGENERATIVE DISEASES